AccessibilityHelpAbout Us
Conexeu Sciences logo

Conexeu Sciences(NASDAQ) CNXU

Market Cap$133.79MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2026)-62%
5 YearN/A
1 YearN/A
1 Month-44%
$4.50
-10.00%
-0.50Today
After hours$4.44-$0.06 (-1.33%)
Conexeu Sciences last closing stock price
MetricPriceDate
Last closeUSD 5.002026-09-14
Conexeu Sciences stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0.6%USD 4.972026-09-04
1 month-43.82%USD 8.902026-08-14
3 month-60.06%USD 12.522026-06-16
Since inception-61.74%USD 13.072026-05-21

Conexeu Sciences Financials at a Glance

Market Cap

$133.79MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$13.63

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

3.40 (High)

Price

$4.50

Volume

124,778.654

Open

$5.00

Previous Close

$4.45

Daily Range

$4.36 - $5.00

52-Week Range

$4.00 - $18.79

Estimated Earnings Date

Sep 30, 2026

CNXU News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Conexeu Sciences

Conexeu Sciences Inc. specializes in pioneering regenerative biomaterials intended for various medical fields, including wound management, dental practices, and aesthetic medicine. Founded in November 2022, the company operates from Reno, Nevada, and is committed to advancing healthcare solutions through innovative technologies.

Products and Services
  • Regenerative biomaterials for wound management
  • Biomaterials tailored for dental applications
  • Aesthetic medicine solutions enhancing patient outcomes
Growth Outlook
  • Market demand for regenerative medicine is rapidly increasing
  • Expansion into new medical fields anticipated in the coming years
  • Strategic partnerships expected to enhance product development
Financial Highlights
  • Market capitalization stands at approximately $132.99 million
  • Stock price has fluctuated between $4.855 and $18.79 in the past year
  • Recent trading volume reached 249,398 shares
Conexeu Sciences Inc. is positioned in a growing sector with significant potential for expansion. The company's focus on innovative biomaterials aligns with increasing market demand, particularly in regenerative medicine. With a solid market capitalization and a diverse product offering, Conexeu is poised for future growth. The recent stock price fluctuations indicate investor interest, while the trading volume reflects active market participation. Overall, Conexeu Sciences Inc. presents a compelling opportunity within the biotechnology industry.
AI Generated • Sep 4, 2026

Industry

Biotechnology

Sector

Health Care

Employees

4

CEO

Miles D. Harrison

Website

www.conexeu.com

Headquarters

Reno, NV 89501, US

CNXU Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

$133.79MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

26.76M

Volume

124.78K

Avg. Volume

173.08K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Conexeu Sciences Performance Analysis

Conexeu Sciences annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-10-31USD 0N/A
20242024-10-31USD 0N/A
20252025-10-31USD 0N/A
Conexeu Sciences annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-10-31USD -0.00N/A
20242024-10-31USD -0.021229.4%
20252025-10-31USD -0.19730.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$0.01

+2.9%

Gross Margin

N/A

N/A

Market Cap

$133.79MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$55.59

N/A

Employees

4

N/A

Net Income

-$7.73

+16.9%

EBITDA

-$7.67

+17.0%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

$2.28

+452.9%

Total Debt

$0.07

+0.7%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.03

+0.3%

Short Term Debt

$0.04

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

-65.70%

N/A

Free Cash Flow

-$6.80

+27.3%

Operating Cash Flow

-$6.76

+28.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,587.01-0.00%
^DJIDJI
$52,024.29-0.01%
^IXICNASDAQ
$25,994.03-0.01%
BTCBitcoin
$76,604.00-0.03%

Trending Stocks

Symbol / CompanyPricePrice Chg
VEEAVeea
$5.71+149.34%
BITOProShares Trust - ProShares Bitcoin ETF
$10.23-3.58%
NVDANvidia
$212.17+0.57%
NOKNokia
$9.84+1.97%

Questions About CNXU

What is the current price of Conexeu Sciences?

Conexeu Sciences is trading at $4.45 per share.

What is the 52-week range for Conexeu Sciences?

Over the past 52 weeks, Conexeu Sciences has traded between $4.00 and $18.79.

How much debt does Conexeu Sciences have?

As of the most recent reporting period, Conexeu Sciences reported total debt of $72.48K.

How much cash does Conexeu Sciences have on hand?

Conexeu Sciences reported $2.21M in cash and cash equivalents in its most recent financial results.

What is Conexeu Sciences’s dividend yield?

Conexeu Sciences does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services